97 related articles for article (PubMed ID: 1559668)
1. The distribution of type IV collagen in invasive carcinoma of the uterine cervix.
Pitt MA; Hale RJ; Buckley CH
Histopathology; 1992 Feb; 20(2):139-43. PubMed ID: 1559668
[TBL] [Abstract][Full Text] [Related]
2. Distribution of type IV collagen immunoreactivity to assess questionable early stromal invasion.
Stewart CJ; McNicol AM
J Clin Pathol; 1992 Jan; 45(1):9-15. PubMed ID: 1740529
[TBL] [Abstract][Full Text] [Related]
3. Basement membranes in cervical cancer: relationship to pelvic lymph node metastasis and prognosis.
Bremer GL; Tiebosch AT; van der Putten HW; de Haan J; Arends JW
Gynecol Oncol; 1995 Jun; 57(3):351-5. PubMed ID: 7539774
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
Hale RJ; Buckley CH; Fox H; Williams J
J Clin Pathol; 1992 Jul; 45(7):594-6. PubMed ID: 1355495
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of basement membrane collagen IV in uterine cervix carcinoma.
Pinto GA; Vassallo J; Andrade LA; Magna LA
Sao Paulo Med J; 1998; 116(6):1846-51. PubMed ID: 10349192
[TBL] [Abstract][Full Text] [Related]
6. The prognosis of adenosquamous carcinomas of the uterine cervix.
Bethwaite P; Yeong ML; Holloway L; Robson B; Duncan G; Lamb D
Br J Obstet Gynaecol; 1992 Sep; 99(9):745-50. PubMed ID: 1420015
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
Hale RJ; Buckley CH; Gullick WJ; Fox H; Williams J; Wilcox FL
J Clin Pathol; 1993 Feb; 46(2):149-53. PubMed ID: 8459036
[TBL] [Abstract][Full Text] [Related]
8. Basement membrane of cervical adenocarcinoma: an immunoperoxidase study of laminin and type IV collagen.
Yavner DL; Dwyer IM; Hancock WW; Ehrmann RL
Obstet Gynecol; 1990 Dec; 76(6):1014-9. PubMed ID: 2234709
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin-D expression in cervical carcinoma and its prognostic significance.
Mitchell KM; Hale RJ; Buckley CH; Fox H; Smith D
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):357-60. PubMed ID: 8322451
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of the extracellular matrix in non-small cell lung cancer: relation to lymph node metastasis and prognosis].
Nakajima I
Hokkaido Igaku Zasshi; 1991 May; 66(3):356-68. PubMed ID: 1885161
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix.
van Bommel PF; Kenemans P; Helmerhorst TJ; Gallee MP; Ivanyi D
Cancer; 1994 Oct; 74(8):2314-20. PubMed ID: 7522949
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract][Full Text] [Related]
13. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
Costa MJ; Walls J; Trelford JD
Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
[TBL] [Abstract][Full Text] [Related]
14. An immunoperoxidase study of laminin and type IV collagen distribution in carcinoma of the cervix and vulva.
Ehrmann RL; Dwyer IM; Yavner D; Hancock WW
Obstet Gynecol; 1988 Aug; 72(2):257-62. PubMed ID: 3292982
[TBL] [Abstract][Full Text] [Related]
15. The pathology of cervical tumours.
Tiltman AJ
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):485-500. PubMed ID: 16150389
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.
Lee IJ; Park KR; Lee KK; Song JS; Lee KG; Lee JY; Cha DS; Choi HI; Kim DH; Deung YK
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):768-79. PubMed ID: 12377329
[TBL] [Abstract][Full Text] [Related]
17. Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18.
Wetzels RH; Schaafsma HE; Leigh IM; Lane EB; Troyanovsky SM; Wagenaar SS; Vooijs GP; Ramaekers FC
Histopathology; 1992 Apr; 20(4):295-303. PubMed ID: 1374358
[TBL] [Abstract][Full Text] [Related]
18. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer.
Tjalma W; Weyler J; Weyn B; Van Marck E; Van Daele A; Van Dam P; Goovaerts G; Buytaert P
Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):251-7. PubMed ID: 10996690
[TBL] [Abstract][Full Text] [Related]
19. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
20. Type IV collagen in the basal membrane of human papillomavirus associated premalignant and malignant squamous cell lesions of the uterine cervix.
Sorvari T; Sarnesto A; Syrjänen K
Gynecol Obstet Invest; 1988; 26(4):324-31. PubMed ID: 2852628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
